Search
for
Sort by
Research 30 of 537
- Becker's Melanosis and Hypertrichosis*
- Autoimmune alopecia areata due to thymoma without myasthenia gravis: a case report
- EFFECT OF PREGNANCY ON BODY HAIR GROWTH IN DAIRY CATTLE
- A CONTRIBUIÇÃO DA NEUROPSICOPEDAGOGIA NA EDUCAÇÃO
- Topical application of vitamin D cream in particiants with inflammatory acne due to vitamin D deficiency
- TEORIA CONCEPCIONISTA PARA A AQUISIÇÃO DA PERSONALIDADE JURÍDICA NO BRASIL
- PROCESSO DE INTERNACIONALIZAÇÃO DAS EMPRESAS
- Thymoma without Myasthenia Gravis Showing Size Fluctuation in Parallel to Alopecia Areata Activity: A Case Report
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Discriminative models of the possibility of occurrence and features of the course of alopecia areata in Ukrainian men depending on the features of body structure and size indicators
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- Alopecia areata in solid organ transplant recipients: A retrospective analysis
- Cephalalgic Alopecia Areata
- Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Efficacy and safety of methotrexate in alopecia areata
- Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Novel drugs of United States Food and Drug Administration approved in 2024
- Hair loss after covid 19 - case series
- Cutaneous Drug Reaction Case Reports
- Dermatologic therapy: December 1986 to December 1987
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- The advantages of hair follicle pluripotent stem cells over embryonic stem cells and induced pluripotent stem cells for regenerative medicine
- Lung Cancer Awareness Symposium Highlights Necessary Focus Areas for Research
- Study of the Thyroid Profile of Patients with Alopecia
- The JAK/STAT signaling pathway: from bench to clinic
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants